Equity Overview
Price & Market Data
Price: $0.399
Daily Change: -$0.0048 / 1.20%
Daily Range: $0.399 - $0.404
Market Cap: $48,168,816
Daily Volume: 15,075
Performance Metrics
1 Week: 1.67%
1 Month: 14.09%
3 Months: 61.20%
6 Months: 59.40%
1 Year: 160.3%
YTD: 24.14%
Details
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.